Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
June-2014 Volume 33 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2014 Volume 33 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis

  • Authors:
    • Y. M. Luo
    • N. X. Xia
    • L. Yang
    • Z. Li
    • H. Yang
    • H. J. Yu
    • Y.  Liu
    • H. Lei
    • F. X. Zhou
    • C. H. Xie
    • Y. F. Zhou
  • View Affiliations / Copyright

    Affiliations: Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University, Wuhan, Hubei, P.R. China, Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, P.R. China
    Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1484-1490
    |
    Published online on: April 2, 2014
       https://doi.org/10.3892/ijmm.2014.1721
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Melanoma has traditionally been viewed as a radioresistant cancer. However, recent studies suggest that under certain clinical circumstances, radiotherapy may play a significant role in the treatment of melanoma. Previous studies have demonstrated that telomere length is a hallmark of radiosensitivity. The newly discovered mammalian CTC1‑STN1-TEN1 (CST) complex has been demonstrated to be an important telomere maintenance factor. In this study, by establishing a radiosensitive/radioresistant human melanoma cell model, MDA-MB-435/MDA-MB‑435R, we aimed to investigate the association of CTC1 expression with radiosensitivity in human melanoma cell lines, and to elucidate the possible underlying mechanisms. We found that CTC1 mRNA and protein levels were markedly increased in the MDA-MB‑435R cells compared with the MDA-MB‑435 cells. Moreover, the downregulation of CTC1 enhanced radiosensitivity, induced DNA damage and promoted telomere shortening and apoptosis in both cell lines. Taken together, our findings suggest that CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. Thus, CTC1 may be an attractive target gene for the treatment of human melanoma.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Miller AJ and Mihm MC Jr: Melanoma. N Engl J Med. 355:51–65. 2006. View Article : Google Scholar

2 

Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar

3 

Little JB, Hahn GM, Frindel E and Tubiana M: Repair of potentially lethal radiation damage in vitro and in vivo. Radiology. 106:689–694. 1973. View Article : Google Scholar : PubMed/NCBI

4 

Jenrette JM: Malignant melanoma: the role of radiation therapy revisited. Semin Oncol. 23:759–762. 1996.PubMed/NCBI

5 

Stevens G and McKay MJ: Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol. 7:575–583. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Rofstad EK: Radiation biology of malignant melanoma. Acta Radiol Oncol. 25:1–10. 1986. View Article : Google Scholar

7 

Overgaard J, Overgaard M, Hansen PV and von der Maase H: Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol. 5:183–192. 1986. View Article : Google Scholar : PubMed/NCBI

8 

Khan N, Khan MK, Almasan A, Singh AD and Macklis R: The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys. 80:645–654. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Arienti C, Tesei A, Carloni S, et al: SLUG silencing increases radiosensitivity of melanoma cells in vitro. Cell Oncol (Dordr). 36:131–139. 2013. View Article : Google Scholar : PubMed/NCBI

10 

de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110. 2005.PubMed/NCBI

11 

Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Baumann P and Price C: Pot1 and telomere maintenance. FEBS Lett. 584:3779–3784. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Wang F and Lei M: Human telomere POT1-TPP1 complex and its role in telomerase activity regulation. Methods Mol Biol. 735:173–187. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Miyake Y, Nakamura M, Nabetani A, et al: RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell. 36:193–206. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Song X, Leehy K, Warrington RT, Lamb JC, Surovtseva YV and Shippen DE: STN1 protects chromosome ends in Arabidopsis thaliana. Proc Natl Acad Sci USA. 105:19815–19820. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Price CM, Boltz KA, Chaiken MF, Stewart JA, Beilstein MA and Shippen DE: Evolution of CST function in telomere maintenance. Cell Cycle. 9:3157–3165. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Mangino M, Hwang SJ, Spector TD, et al: Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet. 21:5385–5394. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Surovtseva YV, Churikov D, Boltz KA, et al: Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol Cell. 36:207–218. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Chen LY, Redon S and Lingner J: The human CST complex is a terminator of telomerase activity. Nature. 488:540–544. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Ning S, Shui C, Khan WB, Benson W, Lacey DL and Knox SJ: Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys. 40:177–187. 1998. View Article : Google Scholar : PubMed/NCBI

21 

Cook PJ, Ju BG, Telese F, Wang X, Glass CK and Rosenfeld MG: Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature. 458:591–596. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Campisi J, Kim SH, Lim CS and Rubio M: Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol. 36:1619–1637. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Smith CD and Blackburn EH: Uncapping and deregulation of telomeres lead to detrimental cellular consequences in yeast. J Cell Biol. 145:203–214. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Maes L, Van Neste L, Van Damme K, et al: Relation between telomerase activity, hTERT and telomere length for intracranial tumours. Oncol Rep. 18:1571–1576. 2007.PubMed/NCBI

25 

Castella M, Puerto S, Creus A, Marcos R and Surralles J: Telomere length modulates human radiation sensitivity in vitro. Toxicol Lett. 172:29–36. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Tang T, Zhou FX, Lei H, et al: Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines. Oncol Rep. 21:1505–1509. 2009.PubMed/NCBI

27 

Ayouaz A, Raynaud C, Heride C, Revaud D and Sabatier L: Telomeres: hallmarks of radiosensitivity. Biochimie. 90:60–72. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Zhou FX, Xiong J, Luo ZG, et al: cDNA expression analysis of a human radiosensitive-radioresistant cell line model identifies telomere function as a hallmark of radioresistance. Radiat Res. 174:550–557. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Drissi R, Wu J, Hu Y, Bockhold C and Dome JS: Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells. Cancer Prev Res (Phila). 4:1973–1981. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Berardinelli F, Nieri D, Sgura A, Tanzarella C and Antoccia A: Telomere loss, not average telomere length, confers radiosensitivity to TK6-irradiated cells. Mutat Res. 740:13–20. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Gu P, Min JN, Wang Y, et al: CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J. 31:2309–2321. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Anderson BH, Kasher PR, Mayer J, et al: Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet. 44:338–342. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Eriksson D and Stigbrand T: Radiation-induced cell death mechanisms. Tumour Biol. 31:363–372. 2010. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo YM, Xia NX, Yang L, Li Z, Yang H, Yu HJ, Liu Y, Lei H, Zhou FX, Xie CH, Xie CH, et al: CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. Int J Mol Med 33: 1484-1490, 2014.
APA
Luo, Y.M., Xia, N.X., Yang, L., Li, Z., Yang, H., Yu, H.J. ... Zhou, Y.F. (2014). CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. International Journal of Molecular Medicine, 33, 1484-1490. https://doi.org/10.3892/ijmm.2014.1721
MLA
Luo, Y. M., Xia, N. X., Yang, L., Li, Z., Yang, H., Yu, H. J., Liu, Y., Lei, H., Zhou, F. X., Xie, C. H., Zhou, Y. F."CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis". International Journal of Molecular Medicine 33.6 (2014): 1484-1490.
Chicago
Luo, Y. M., Xia, N. X., Yang, L., Li, Z., Yang, H., Yu, H. J., Liu, Y., Lei, H., Zhou, F. X., Xie, C. H., Zhou, Y. F."CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis". International Journal of Molecular Medicine 33, no. 6 (2014): 1484-1490. https://doi.org/10.3892/ijmm.2014.1721
Copy and paste a formatted citation
x
Spandidos Publications style
Luo YM, Xia NX, Yang L, Li Z, Yang H, Yu HJ, Liu Y, Lei H, Zhou FX, Xie CH, Xie CH, et al: CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. Int J Mol Med 33: 1484-1490, 2014.
APA
Luo, Y.M., Xia, N.X., Yang, L., Li, Z., Yang, H., Yu, H.J. ... Zhou, Y.F. (2014). CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. International Journal of Molecular Medicine, 33, 1484-1490. https://doi.org/10.3892/ijmm.2014.1721
MLA
Luo, Y. M., Xia, N. X., Yang, L., Li, Z., Yang, H., Yu, H. J., Liu, Y., Lei, H., Zhou, F. X., Xie, C. H., Zhou, Y. F."CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis". International Journal of Molecular Medicine 33.6 (2014): 1484-1490.
Chicago
Luo, Y. M., Xia, N. X., Yang, L., Li, Z., Yang, H., Yu, H. J., Liu, Y., Lei, H., Zhou, F. X., Xie, C. H., Zhou, Y. F."CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis". International Journal of Molecular Medicine 33, no. 6 (2014): 1484-1490. https://doi.org/10.3892/ijmm.2014.1721
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team